Liver Tumor Surgery: A Complete Guide

Liver tumors require different surgical approaches depending on whether they are benign or malignant. Accurate diagnosis and timely surgery directly determine the success of treatment.

Liver Tumor Surgery: What Is Done for Which Tumor?

Liver tumors can be benign or malignant, and each tumor type requires a different surgical approach. The size, location, number, and liver function all directly determine the surgical plan. Accurate diagnosis and an experienced surgical team are the two most critical components of this process.

What Is Meant by a Liver Tumor?

Not every mass detected in the liver carries the same meaning. Patients who encounter the terms "lesion" or "mass" on imaging often arrive at the clinic with great anxiety; yet a significant proportion of these masses are benign and can be lived with for years without any symptoms. The first and most decisive step in the surgical decision-making process is to definitively determine whether the tumor is benign or malignant. This distinction directly shapes both the treatment strategy and the extent of surgery.

What Are Benign Tumors?

Benign liver tumors do not spread to surrounding tissues or metastasize to distant organs. Nevertheless, depending on size, location, and symptomatic status, some may require surgical intervention. The three most commonly encountered benign tumors in clinical practice are hemangioma, adenoma, and focal nodular hyperplasia.

What Is a Liver Hemangioma and Why Does It Matter?

Hemangioma (liver vascular tumor) is the most common benign mass seen in the liver. It is estimated to occur in approximately five percent of the population, and the vast majority are discovered incidentally during routine ultrasound or CT scans. Small hemangiomas generally cause no symptoms and may remain unchanged for years. However, large hemangiomas — particularly those exceeding 5 centimeters — require more careful monitoring due to the risk of abdominal pain, a feeling of fullness, or, in rare cases, rupture. The surgical decision is made not based on size alone, but on the presence of symptoms, growth rate, and the patient's overall condition. Very large cavernous hemangiomas can lead to Kasabach-Merritt syndrome and may be confused with portal vein thrombosis.

In Whom Does Liver Adenoma Occur?

Liver adenoma is a tumor seen particularly in young women who have used oral contraceptives (birth control pills) for a prolonged period. Anabolic steroid use and glycogen storage diseases are also counted among the risk factors. The clinical significance of adenoma stems from the risks of malignant transformation (conversion to a malignant tumor) and bleeding. For this reason, watchful waiting alone may not be sufficient in patients diagnosed with adenoma; size, hormonal use history, and genetic subtype are the main factors determining the surgical decision.

How Is Focal Nodular Hyperplasia (FNH) Distinguished from Adenoma?

Focal nodular hyperplasia (FNH) is a benign mass composed of normal liver cells but with an irregular architecture. It carries no risk of malignant transformation and the vast majority do not require surgery. However, situations where imaging findings overlap with those of adenoma can challenge the clinician. Magnetic resonance imaging (MRI), especially when hepatobiliary contrast agents are used, is the most reliable method for distinguishing between the two tumors. When diagnostic uncertainty persists, biopsy may be considered.

What Are Malignant Tumors?

Among the primary (originating from the liver) malignant tumors of the liver, the most commonly seen are hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Both offer the chance of curative surgical treatment when detected at an early stage; however, diagnosis is often made at an advanced stage. For this reason, the inclusion of individuals in high-risk groups in regular screening programs is of great importance.

Why Does Hepatocellular Carcinoma (HCC) Require Particular Attention?

Hepatocellular carcinoma (HCC) is a primary liver cancer originating from liver cells and is the most commonly seen primary liver cancer worldwide. Chronic hepatitis B, hepatitis C infection, and liver cirrhosis (hardening and loss of function of liver tissue) are the most important risk factors for the development of HCC. The fundamental factor that complicates surgical planning is that the tumor frequently develops on the background of an already damaged liver. The severity of the underlying liver disease directly affects both the resection (tumor removal) decision and transplant eligibility.

What Is Intrahepatic Cholangiocarcinoma?

Intrahepatic cholangiocarcinoma is a malignant tumor originating from the bile ducts within the liver. It is seen less frequently than HCC; however, due to diagnostic difficulty, it is often detected at an advanced stage. Imaging findings can sometimes be confused with other liver tumors, making pathological confirmation critically important. Surgery at an early stage remains the most effective treatment option for long-term survival.

How Is the Decision to Operate Made?

In liver surgery, the decision to operate is not made by looking at the presence of a tumor alone. The patient's general health status, liver function, the anatomical location and vascular relationships of the tumor, comorbidities, and the expected surgical risk are all evaluated as a whole. This is a field where experience directly influences outcomes; every case requires its own individualized plan.

Which Tests Determine the Surgical Plan?

Imaging methods form the cornerstone of surgical planning. Computed tomography (CT) and magnetic resonance imaging (MRI) reveal the size, number, vascular relationships, and location of the tumor within the liver. Positron emission tomography (PET-CT) is used to evaluate distant organ metastases (spread of the tumor to other organs). Tumor markers — particularly alpha-fetoprotein (AFP) for HCC and CA 19-9 for cholangiocarcinoma — can provide guidance in diagnosis and follow-up. Liver function tests play a critical role in predicting whether the remaining liver will be able to bear the load after surgery.

Why Is Liver Reserve So Important?

Liver reserve refers to the amount and functional capacity of healthy liver tissue that will remain after surgery. Extensive resections performed without adequate reserve can lead to post-operative liver failure. For this reason, surgeons measure the volume of the remaining liver preoperatively using computerized volumetry. In a healthy liver, twenty-five percent of the total volume is considered sufficient, whereas on the background of cirrhosis this threshold may rise to forty percent or higher.

Why Is the Tumor's Relationship to Vascular Structures Critical?

The liver is surrounded by major vascular structures such as the portal vein (the main vessel carrying blood from the intestines), hepatic arteries (vessels carrying oxygen to the liver), and hepatic veins (vessels returning blood from the liver to the heart). The proximity of the tumor to these vessels, or its encasement of them, determines whether resection is technically feasible. While vascular invasion (spread of the tumor to the vessel wall) may complicate surgery in some cases, in experienced hands surgery can be performed with vascular reconstruction.

What Is the Role of a Multidisciplinary Tumor Board?

The treatment decision for liver tumors is the product of the joint assessment of a multidisciplinary tumor board — consisting of a liver surgeon, medical oncologist, radiologist, nuclear medicine specialist, and pathologist — rather than a single physician. This structure ensures that each patient's condition is considered from different specialist perspectives. The board's decision forms the scientific basis of the treatment plan presented to the patient.

How Can a Board Decision Change the Surgical Plan?

In some patients, the tumor may not appear suitable for direct surgery at initial assessment. In such cases, the board may recommend systemic chemotherapy or local ablation (a method of destroying the tumor with heat or cold) first. Surgery is planned after the tumor has shrunk sufficiently; this approach is referred to as "bridge therapy" or "conversion therapy." In some cases, the opposite process applies: additional interventions may be required to increase liver reserve before surgery.

When Is Surgery Required for Benign Tumors?

The vast majority of benign liver tumors can be monitored for years without any intervention. "I have a tumor but my doctor said let's wait — is that correct?" is one of the questions frequently encountered in the clinic. The answer is often yes; however, this monitoring decision requires certain criteria to be regularly reassessed at defined intervals.

What Are the Indications for Surgery in Liver Hemangioma?

The vast majority of hemangiomas, regardless of their size, do not require surgery. Nevertheless, surgery may be considered in the following situations:

• Presence of significant symptoms such as abdominal pain, nausea, or early satiety
• The tumor showing a tendency for rapid growth
• Large or superficial hemangiomas with a high risk of rupture
• Inability to definitively distinguish from a malignant tumor on imaging

Annual ultrasound follow-up is generally sufficient for asymptomatic, stable hemangiomas.

Which Technique Is Used in Hemangioma Surgery?

Two basic approaches are used in hemangioma surgery: enucleation and resection. Enucleation is the process of peeling the tumor away from the healthy liver tissue; this method preserves healthy liver tissue. In resection, the surrounding liver tissue is removed along with the tumor. In suitable cases, a laparoscopic (minimally invasive) approach may be preferred; this method aims for a shorter hospital stay and faster recovery.

Is Surgery Inevitable for Liver Adenoma?

Adenoma is the tumor among benign tumors for which the surgical decision must be made most carefully. For adenomas exceeding 5 centimeters in size, surgery is generally recommended due to the risks of malignant transformation and bleeding. Discontinuation of oral contraceptive use may cause some adenomas to shrink; therefore, hormonal use history is an integral part of the treatment plan. Small, asymptomatic, and stable adenomas can be monitored with close imaging surveillance.

How Much of the Liver Is Removed in Adenoma Surgery?

The aim in adenoma surgery is to remove the tumor with adequate surgical margins while preserving liver reserve. Anatomic resection is the removal of a specific segment (section) of the liver in accordance with its vascular boundaries. Non-anatomic resection is the approach in which the tumor is removed without being bound to anatomical boundaries. Non-anatomic resection is frequently preferred in adenoma cases; this prevents unnecessary loss of liver tissue.

What Surgical Options Are Available for Malignant Tumors?

In malignant liver tumors, surgery is the cornerstone of curative treatment. The surgical option is determined by the type, stage, number, location within the liver, and the patient's liver reserve. The most frequently applied surgical approaches are discussed in detail below.

What Is Liver Resection and How Is It Performed?

Resection is the surgical removal of the portion of the liver containing the tumor. The liver is anatomically divided into right and left lobes and eight segments. This anatomical structure allows the surgeon to calculate in advance which portion will be removed and the adequacy of the remaining tissue.

What Is the Difference Between Right and Left Lobectomy?

The right lobe of the liver accounts for approximately sixty to seventy percent of the total liver volume. Right lobectomy represents a greater tissue loss compared to left lobectomy, and the adequacy of the remaining liver reserve must be calculated more carefully. Left lobectomy results in a smaller volume loss; therefore, the risk of post-operative liver failure is comparatively lower. Preoperative volumetric calculation is mandatory for both approaches.

Can Laparoscopic Liver Resection Be Applied to Everyone?

Laparoscopic (minimally invasive) liver resection, in suitable cases, aims for less blood loss, a shorter hospital stay, and faster recovery compared to open surgery. However, not every patient is suitable for this approach. The size, location, and vascular relationships of the tumor, as well as the patient's general condition, determine the feasibility of the laparoscopic approach.

What Is the Difference Between Robotic Liver Surgery and Laparoscopic Surgery?

The robotic surgical platform goes a step beyond laparoscopic surgery with its tremor-filtering system that filters the surgeon's hand movements and its three-dimensional high-resolution imaging. Particularly in narrow anatomical spaces and in cases requiring precise dissection, the robotic approach can increase the surgeon's freedom of movement. Which cases the robotic platform will be preferred for varies depending on the surgeon's experience and the institution's technical infrastructure.

When Is Liver Transplantation Considered for HCC?

In hepatocellular carcinoma, liver transplantation is the only option that simultaneously treats both the tumor and the underlying cirrhosis. In HCC patients where resection cannot be performed or where liver reserve is insufficient, transplantation may be the most effective treatment method for long-term survival. The transplantation decision is evaluated within the framework of the internationally accepted Milan criteria.

What Happens If the Tumor Grows While Waiting for a Transplant?

The organ waiting process carries the risk of tumor progression in HCC patients. During this period, bridge therapies are applied to keep the tumor under control and to ensure that the patient retains transplant eligibility criteria. Transarterial chemoembolization (TACE) is the process of cutting off the tumor's blood supply by administering drugs and embolic agents into the hepatic artery. Transarterial radioembolization (TARE) involves delivering radioactive microspheres to the tumor for targeted internal radiation therapy; it both provides tumor control and can contribute to increasing the volume of the remaining liver before transplantation. Radiofrequency ablation (RFA) involves destroying the tumor with thermal energy. These methods aim to slow or halt tumor growth in patients awaiting transplantation. For more information about the role of liver transplantation in colorectal cancer metastases, you can review the article on Liver Transplantation in Colorectal Metastases.

How Is Surgery Planned for Intrahepatic Cholangiocarcinoma?

The primary determinant of surgical success in intrahepatic cholangiocarcinoma is achieving a negative surgical margin; that is, removing the tumor with a sufficient amount of healthy tissue surrounding it. Lymph node dissection (clearance of regional lymph nodes) may be required in this tumor, as lymph node involvement is a critical determinant of long-term prognosis.

What Is the Surgical Approach for Extrahepatic Cholangiocarcinoma?

Extrahepatic cholangiocarcinoma develops in the bile ducts outside the liver, and the surgical strategy varies depending on the location of the tumor. Hilar (Klatskin) tumors frequently require extended liver resection combined with bile duct excision and biliary reconstruction. For distal bile duct tumors, pancreaticoduodenectomy (Whipple procedure) may be applied. In both cases, achieving a negative surgical margin and performing regional lymph node dissection are factors that directly affect long-term survival.

Why May Biliary Reconstruction Be Required?

Intrahepatic cholangiocarcinoma may develop in a location close to or involving the bile ducts. After resection, additional surgical steps may be required to restore bile flow. Hepaticojejunostomy — the creation of a new connection between the bile duct and the small intestine — is frequently performed in these cases. This additional procedure increases the duration and complexity of surgery; therefore, planning by an experienced surgical team is of great importance.

How Is Preoperative Preparation Carried Out?

Preparation for liver surgery is not limited to imaging and blood tests alone. Ensuring that the patient enters surgery in the best physical and metabolic condition directly affects both surgical safety and the recovery process.

Why Is Portal Vein Embolization Applied?

When extensive resection is planned, the adequacy of the remaining liver tissue after surgery is calculated in advance. When the remaining liver volume appears insufficient, an interventional radiology procedure called portal vein embolization (PVE) may be applied. In this procedure, the portal vein branch supplying the liver segment to be removed is blocked; this redirects blood flow to the remaining liver, which then begins to grow. PVE is one of the most effective methods for increasing preoperative liver reserve.

How Long Is the Wait After PVE?

After the PVE procedure, a wait of generally four to six weeks is required for the remaining liver to grow sufficiently. During this period, liver volume is remeasured with computed tomography. When the remaining liver volume reaches the targeted threshold, surgery is planned; if it does not, additional strategies may be considered. Although this waiting period may sometimes require patience from patients, it is indispensable in terms of surgical safety.

Does Nutritional and Physical Preparation Affect Surgical Outcomes?

Preoperative nutritional status and muscle mass are among the factors that directly affect the recovery process. Malnutrition and sarcopenia (muscle loss) may increase the risk of postoperative complications. For this reason, prehabilitation — programs aimed at improving the patient's physical capacity and nutritional status during the preoperative period — has become an integral part of modern liver surgery. Dietitian support, light exercise programs, and nutritional supplementation when needed constitute the components of this process.

How Does the Postoperative Process Work?

Knowing how the postoperative process will work addresses one of the greatest concerns of patients at the decision-making stage. This process varies from person to person depending on the type of tumor, the surgical technique applied, and the patient's general condition.

How Long Is the Hospital Stay After Liver Surgery?

For laparoscopic cases, the hospital stay is generally planned as three to five days. In cases requiring open surgery, this period may extend to five to ten days. In extensive resections or cases where additional procedures have been applied, the length of stay may be longer. It is not possible to promise a definitive period; individual recovery speed, postoperative liver function, and complication status are the main factors determining this duration.

Can the Liver Regenerate Itself?

The liver is the organ with the greatest regeneration (renewal) capacity in the human body. Under conditions of adequate reserve, a large portion of the removed liver tissue can regrow within a few months. This biological characteristic is the fundamental factor that makes extensive resections possible. In clinical practice, it is observed that the remaining left lobe after right lobectomy reaches a significant portion of its initial volume within six to eight weeks.

What Complications May Occur After Surgery?

As with any major surgical procedure, there is a risk of complications in liver surgery. Conveying these risks honestly enables the patient to manage the process with realistic expectations. The most frequently encountered complications are as follows:

• Bile leak: Leakage of bile from the bile ducts into the abdominal cavity; manageable with drainage in most cases.
• Postoperative liver failure: Failure of the remaining liver to adequately assume its function; rare but a serious complication.
• Infection and abscess: Intra-abdominal infection foci; treatable with antibiotic therapy or drainage.
• Bleeding: May develop during or after surgery; the risk is minimized by experienced teams.

The vast majority of these complications, when recognized early, can be managed with non-surgical methods. Close follow-up by an experienced team ensures that complications are detected at an early stage.

What Are the Signs of Complications and When Should a Physician Be Consulted?

If the following symptoms appear after discharge, a physician or emergency room should be consulted without delay:

• Fever above 38 degrees Celsius
• Progressively worsening abdominal pain
• Yellowing of the skin and eyes (jaundice)
• Dark-colored urine or pale stools
• Discharge, redness, or swelling at the wound site
• Sudden shortness of breath or palpitations

How Is Follow-Up Conducted After Discharge?

Follow-up after liver surgery is an integral part of treatment. During the first year, computed tomography or magnetic resonance imaging is generally performed every three to four months. Tumor markers (AFP, CA 19-9) are measured at regular intervals. From the second year onward, follow-up intervals may be extended. For patients coming from abroad or living in different cities, a portion of follow-up examinations can be conducted remotely via telemedicine consultations. For detailed information about the home care process after liver transplantation, you can review the Home Care After Liver Transplant page.

You can make an appointment to evaluate your situation and create a personalized roadmap. Forwarding your existing imaging and pathology reports in advance will ensure that the initial consultation is more productive.